Join Now

Category Archives: BioUtah News

Myriad Genetics Earns 2024 Great Place To Work® Certification™

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has received the Great Place To Work Certification for the second year in a row. The certification is based entirely on what current employees say about their experience working at […]

| Comments Off on Myriad Genetics Earns 2024 Great Place To Work® Certification™

Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®

SOUTH JORDAN, Utah, July 01, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million. EndoGastric Solutions’ EsophyX® Z+ device delivers a durable, minimally invasive non-pharmacological treatment […]

| Comments Off on Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®

FDA Clears Balloon Dilation Scoring and Constraining Platform to Treat Small or Distal Peripheral Vasculature

Transformative Angioplasty Sheath Platform Compatible with a Broad Range of Off-the-Shelf PTA and PTCA Angioplasty Balloons Cleared by FDA

| Tagged | Comments Off on FDA Clears Balloon Dilation Scoring and Constraining Platform to Treat Small or Distal Peripheral Vasculature

Renew Biotechnologies

Renew Biotechnologies is a dynamic holding company dedicated to acquiring, developing, and commercializing impactful biotechnology.

| Tagged | Comments Off on Renew Biotechnologies

bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini

Marcy-l’Étoile (France), June 26th, 2024 – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments). The COVID-19 pandemic demonstrated the need for healthcare professionals to […]

| Comments Off on bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini

Foldax® Reports Positive Clinical Results for TRIA Mitral Surgical Heart Valve Using Novel LifePolymer Material

SALT LAKE CITY – June 11, 2024 – Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a prospective, multicenter, single-arm, clinical study of the TRIA™ mitral surgical heart valve with LifePolymer™ conducted in India. At 30 days following surgery, TRIA demonstrated favorable safety and hemodynamics, […]

| Comments Off on Foldax® Reports Positive Clinical Results for TRIA Mitral Surgical Heart Valve Using Novel LifePolymer Material

BioUtah Organizes Stryker, bioMérieux Tours for State Legislators

State legislators got a first hand look at Utah’s life sciences industry.

| Comments Off on BioUtah Organizes Stryker, bioMérieux Tours for State Legislators

New FDA Cleared Balloon Catheter Used for Vessel Occlusion During Patient Resuscitation

Temporary vessel occlusion a growing practice for trauma patients.

| Tagged | Comments Off on New FDA Cleared Balloon Catheter Used for Vessel Occlusion During Patient Resuscitation

SINTX TECHNOLOGIES TO EXPLORE STRATEGIC OPPORTUNITIES

SINTX Technologies announced that its Board of Directors has initiated a process to explore potential strategic options for the Company.

| Tagged | Comments Off on SINTX TECHNOLOGIES TO EXPLORE STRATEGIC OPPORTUNITIES

PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care

Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway

| Tagged | Comments Off on PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care

Medicare Issues Final Coverage Determination for kidneyintelX.dkd

Company has Achieved Prerequisites for Growing Test Adoption with FDA Authorization, Clinical Outcomes Data, Inclusion in Clinical Guidelines, and Broad Insurance Coverage

| Tagged | Comments Off on Medicare Issues Final Coverage Determination for kidneyintelX.dkd

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform

The Company expects that the application for OTC clearance will shortly be followed by pursuit of POC clearance, with other tests in the pipeline to meet the needs of a global market

| Tagged | Comments Off on Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform